S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial

Bibliographic Details
Main Authors: Schmoll, H, Wittig, BW, Arnold, DA, Riera-Knorrenschild, JRK, Nietsche, DN, Kroening, HK, Mayer, FM, Andel, JA, Ziebermayr, RZ, Scheithauer, WS
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072008/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072008/

Similar Items